Topical Minoxidil Side Effects: Rare but Serious Adverse Events

What does the label tell you to watch for?

The OTC Drug Facts labels for 5% minoxidil, the men's solution and the women's foam, direct users to stop use if chest pain, rapid heartbeat, faintness, or dizziness occurs, if sudden unexplained weight gain occurs, if the hands or feet swell, if scalp irritation or redness occurs, or if unwanted facial hair growth occurs [1][2]. Topical trials reported more local irritation with 5% solution than with 2% or placebo in men, and more irritation and hypertrichosis with 5% than with 2% or placebo in women [6][5].

Both labels advise getting medical advice before use in people with heart disease, and say not to use the product if the scalp is red, inflamed, infected, irritated or painful, if other medicines are being used on the scalp, or if the user is under 18 [1][2]. The labels say to keep the product out of reach of children and to get medical help or contact a Poison Control Center if it is swallowed [1][2]. The men's 5% solution is labeled for men only [1].

How much minoxidil gets into the blood?

A comprehensive review states that approximately 1.4% of topical minoxidil is absorbed through the skin [3].

The men's 5% solution label directs users to apply 1 mL to the scalp twice daily, and the women's 5% foam label directs half a capful once daily [1][2]. Both labels also say that using more or more often will not improve results and that continued use is necessary or hair loss will begin again [1][2].

Can topical minoxidil cause heart problems?

The topical labels' cardiac content is a caution plus a symptom list: medical advice before use in people with heart disease, and a stop-use signal for chest pain, rapid heartbeat, faintness or dizziness [1][2].

Minoxidil's cardiac reputation comes from the oral tablets. At antihypertensive doses minoxidil raises pulse rate and causes sodium and water retention, and it is infrequently associated with an idiosyncratic pericardial effusion; it is generally given with a diuretic and a beta blocker to counter those effects [7].

At the much lower oral doses used off-label for hair loss, a retrospective multicenter study of 1404 patients found lightheadedness in 1.7%, fluid retention in 1.3% and tachycardia in 0.9%, with no life-threatening adverse effects observed [8]. A 2025 meta-analysis of oral doses of 5 mg a day or less found a mean heart rate increase of 2.67 beats per minute and hypotensive symptoms in 119 patients (5.0%), with no hypotensive episodes recorded [9].

Fluid retention, swelling and weight gain

Sudden unexplained weight gain and swelling of the hands or feet are both on the topical labels' stop-use list [1][2]. Sodium and water retention is an established effect of oral minoxidil at antihypertensive doses [7], and at low oral doses fluid retention was reported in 1.3% of 1404 patients [8].

Scalp reactions and propylene glycol allergy

Irritant and allergic contact dermatitis on the scalp are the most common adverse reactions of the topical formulation, and some solutions contain propylene glycol, to which allergic reactions have been reported [4].

In a 48-week trial of 393 men, pruritus and local irritation were more frequent with the 5% solution than with 2% or placebo [6]. In a 48-week trial of 381 women, pruritus, irritation and hypertrichosis were all more frequent with 5% than with 2% or placebo [5].

In a 24-week trial of 113 women, once-daily 5% minoxidil foam, a propylene glycol-free formulation, had significantly lower rates of local intolerance than twice-daily 2% propylene glycol-containing solution, especially pruritus and dandruff (P=.046) [10]. Both labels say not to apply the product to a scalp that is red, inflamed, infected, irritated or painful, and list scalp irritation or redness as a reason to stop use [1][2].

Unwanted facial hair

Unwanted facial hair growth is on the labels' stop-use list [1][2]. In the 48-week trial in women it was reported more often with the 5% solution than with 2% or placebo [5].

Pregnancy, breastfeeding and children

Both labels state that the product may be harmful if used when pregnant or breast-feeding [1][2]. The women's label also lists hair loss associated with childbirth among the reasons not to use it [2]. Neither product is intended for anyone under 18, and both say not to use it on babies and children [1][2].

On January 14, 2026, the FDA approved labeling supplements for all three Rogaine new drug applications, adding statements to cartons, containers and consumer booklets to keep the product out of reach of pets and to avoid contact between children and minoxidil application sites [11].

Topical and oral minoxidil are not the same product

Minoxidil tablets are a prescription treatment for severe hypertension, while topical minoxidil is sold over the counter for hair regrowth [12][13][7].